The under-the-radar biotech that roared more than 20 percent Monday on a big deal with AstraZeneca. Is there more room to run? » Subscribe to CNBC: …
source CNBC
Inovio Pharmaceuticals CEO: Navy Seal Of Cancer Fighting | Mad Money | CNBC
The under-the-radar biotech that roared more than 20 percent Monday on a big deal with AstraZeneca. Is there more room to run? » Subscribe to CNBC: …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More